Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Market Movers
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Value
New
Ideas
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Experts
Portfolio
News
Enterprise Solutions
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Arrived
EquityMultiple
Follow Us
More
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Calculators
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
ANTX
Stock Latest News
Ratings
Optimistic Buy Rating for AN2 Therapeutics Driven by Strong Phase 2 Results and Strategic FDA Alignment
14d ago
ANTX
Premium
The Fly
AN2 Therapeutics submits amended EBO-301 trial statistical analysis plan to FDA
14d ago
ANTX
Premium
The Fly
Citizens JMP healthcare analysts hold an analyst/industry conference call
20d ago
ANTX
INSM
Premium
The Fly
JMP Securities healthcare analysts hold an analyst/industry conference call
2M ago
ANTX
INSM
Premium
The Fly
AN2 Therapeutics downgraded to Hold from Buy at TD Cowen
4M ago
ANTX
Premium
The Fly
AN2 Therapeutics reports Q3 EPS (43c), consensus (38c)
4M ago
ANTX
Premium
Company Announcements
AN2 Therapeutics Promotes Joshua Eizen to Key Roles
4M ago
8K
ANTX
Premium
The Fly
AN2 Therapeutics gets continuation grant to discover novel boron based therapies
5M ago
ANTX
Premium
The Fly
AN2 Therapeutics adopts limited duration stockholder rights plan
7M ago
ANTX
Premium
The Fly
AN2 Therapeutics reports Q2 EPS (48c), consensus (59c)
7M ago
ANTX
Premium
The Fly
Morning Movers: Iteris skyrockets following take-private agreement
7M ago
CGC
ITI
Premium
The Fly
AN2 Therapeutics downgraded to Underperform from In Line at Evercore ISI
7M ago
ANTX
Premium
The Fly
AN2 Therapeutics to terminate Phase 2, Phase 3 parts of EBO-301 trial
7M ago
ANTX
Premium
The Fly
AN2 Therapeutics downgraded to Market Perform from Outperform at Leerink
7M ago
ANTX
Premium
The Fly
AN2 Therapeutics price target lowered to $3 from $6 at JMP Securities
7M ago
ANTX
Premium
Company Announcements
AN2 Therapeutics Announces Major Restructuring and Cost-Cutting Measures
7M ago
8K
ANTX
Premium
The Fly
Intuit initiated, Charter downgraded: Wall Street’s top analyst calls
8M ago
PR
LPG
Premium
The Fly
AN2 Therapeutics price target lowered to $2 from $7 at Evercore ISI
10M ago
ANTX
Premium
The Fly
AN2 Therapeutics reports Q1 EPS (56c), consensus (62c)
10M ago
ANTX
Premium
The Fly
AN2 Therapeutics upgraded to Outperform from Market Perform at JMP Securities
11M ago
ANTX
Premium
Company Announcements
AN2 Therapeutics’ High-Stakes Gamble: Navigating FDA Approval for Epetraborole Amid Clinical Trial Uncertainties
11M ago
ANTX
Premium
The Fly
AN2 Therapeutics reports Q4 EPS (57c), consensus (75c)
12M ago
ANTX
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >
You need to enable JavaScript to run this app.
